Tornbjörn Bjerke

Karolinska Development

Chief Executive Officer of Karolinska Development since 2011. Karolinska Development, listed on NASDAQ OMX, aims to create value for patients, researchers, and investors by developing innovations from world class science into products. Bjerke has over 20 years of experience in the pharmaceutical industry, including as President and CEO of Orexo, President and CEO of Biolipox and Director of Pharmacology at AstraZeneca.


Innovating needs leadership

Related contents
"Innovating costs: profitable models for financing innovation. "
"Karolinska Development: Pharmaceutical innovation from a Swedish point-of-view. "